Mosaad M. El Gammal

Ebid, A. - H. I. M., ahmed hossam, M. E. M. Gammal, S. Soror, N. O. M. Mangoud, and M. A. Mahmoud, "High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination", JOURNAL OF CHEMOTHERAPY, vol. 2021, issue 12, 2021.

Ahmed A. Alnagar1, Asmaa A. Mahmoud1, Mosaad M. EL Gammal2, N. H. 3, and M. A. Samra2., "Outcome of Core Binding Factor Acute Myeloid Leukemia by Receptor Tyrosine Kinase Mutation", Clinical lymphoma, myeloma & leukemia , vol. 20, issue 7, pp. 459-67, 2020.

Rasekh1, E. O., G. M. Elsayed1, Y. M. Madney3, and M. E. M. Gammal, "Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia", Clinical lymphoma, myeloma & leukemia , vol. 20, issue 3, pp. 156-67, 2020.

Aal, A. A. A., R. A. Afify, A. S. Zaher, M. E. M. Gammal, and A. M. Atef, "Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia", Hematology, vol. 20, issue 9, pp. 504-510, 2015.

Mosaad M. El Gammal1, M. S. A. 1, N. I. H. 2, and M. A. A. Fatah3, "Superiority of CyBorD Over VAD is More Evident in First than in Second Line Treatment of Multiple Myeloma", Annals of Blood Cancer, vol. 2, issue 1, pp. 1008, 2019. 4._superiority_of_cybord_over_vad_is_more_evident_in_first_than_in_second_line_treatment_of_multiple_myeloma.pdf

Mosaad M. El Gammal1, G. T. Ebied2, Y. M. Madney3, 4 Omnia M. Abo-Elazm, A. K. Kelany, and J. R. 66 P. Olga S. Torra, "Clinical effect of combined mutations in DNMT3A, FLT3-ITD and NPM1 among Egyptian acute myeloid leukemia patients", Clinical lymphoma, myeloma & leukemia , vol. 19, issue 6, pp. pp. e281-e290 , 2019.

Mosaad M. El Gammal1, H. M. Owaidat, R. A. Rashed, R. A. Fatah, and undefined, "Prognostic and therapeutic value of day 14 bone marrow aspiration in adult Acute Myeloid Leukemia patients", Clinical lymphoma, myeloma & leukemia , vol. 19, issue 7, pp. pp. e406-e413, 2019.

Ibrahim, N. H., M. S. Abdellateif, S. H. ‐A. Kassem, M. A. A. E. Salam, and M. M. El Gammal, "Diagnostic significance of miR‐21, miR‐141, miR‐18a and miR‐221 as novel biomarkers in prostate cancer among Egyptian patients", Andrologia, vol. 2019, issue 00, pp. 13384., 2019. 2._diagnostic_significance_of_mir-21_mir-141_mir-18a_and_mir-221_as_novel_biomarkers_in.pdf

heba Zawahry, E., and M. E. M. Gammal, "Cost and outcome of treatment of adults with acute myeloid leukemia at the National Cancer Institute-Egypt", Journal of National Cancer Institute, vol. 19, issue 2, pp. 106-113, 2007.

Yakout, T., M. E. M. Gammal, A. Elias, and O. Khoreshid, "Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia. ", ASCO 2013, USA, 5/2013.